Aluminum is suspected to play a role in several neurological disorders. Reactive oxygen species (ROfi) lead to oxidative stress, which is thought to be a possible mechanism for neurological damage. Interactions between aluminum and iron, a known promoter of prooxidant events, were studied in cerebral tissues using a fluorescent probe to measure rates of generation of ROS. A12(SO4)3 alone failed to stimulate ROfi production over a wide range of concentrations (50-1000 #M). The aluminum-deferrioxamine chelate in the absence of iron could also not potentiate ROS formation. However, A12(SO1)~ potentiated FeSO4-induced ROS, with a maximal effect at 10 #M Fe and 500 #M AI. Kaolin, a hydrated aluminum silicate, did not potentiate ironinduced ROS formation. Ferritin had a minor stimulatory effect on ROS generation, but this was not potentiated by the concurrent presence of A12(SO4)3. Transferrin had no effect on basal rates of ROS generation, but when A12(SO4)3 was also present, ROS production was enhanced. It is concluded that:
1. There is a potentiation of iron-induced ROS by aluminum salts; 2. Free or complexed aluminum alone is not a key producer of ROS; and 3. High rates of ROS production are unlikely to be owing to the displacement by aluminum iron from its biologically sequestered locations.
INTRODUCTION
The capacity of iron in a low-mol-wt form to stimulate biological lipid peroxidation is well known. This property has been reported to be enhanced within neural tissues by aluminum salts (Gutteridge et al., 1985; Aruoma et al., 1989; Fraga et al., 1990 ). The phenomenon is puzzling, in view of the inability of aluminum ions to undergo the changes in valency, characteristic of transition metals that accounts for their potential to promote excess pro-oxidant activity within cells. Neither does aluminum have a strong affinity for sulfhydryl groups. Although the intrinsic capacity of aluminum to induce the generation of free radicals has been reported, this may depend on the concurrent presence of iron (Fraga et al., 1990; Oteiza et al., 1993) .
In view of the proposed association between Alzheimer disease and cerebral aluminum content (McLachlan et al., 1989) , illumination of the effects of aluminum on cerebral metabolism may be important. The potentially pro-oxidant role of aluminum is especially relevant because of the reported presence of excess oxidative activity in both the aged brain, and more specifically, in those regions of the Alzheimer brain showing the most pronounced pathological changes (Smith et al., 1991) . Iron and aluminum are present at high concentrations in neurofibrillary tangles (Good et al., 1992) and may cooperate in the promotion of physiological aggregation of the fl-amyloid peptide (Shigematsu and McGeer, 1992; Mantyh et al., 1993) . Such aggregation may be the result of oxidative events (Hensley et al., 1994) . Lipid peroxidation rates are also elevated in autopsy samples of Alzheimer cortex (Subbarao et al., 1990) , and there is other evidence of an association between this disease and oxidative stress (Pappola et al., 1992) . Excess levels of iron together with aluminum have also been found in the substantia nigra of Parkinsonian patients (Hirsch et al., 1991) , and aluminum accumulates within neurons in amyotrophic lateral sclerosis-Parkinsonian dementia of Guam (Perl et al., 1982) .
The current study was designed both to confirm such interactions between iron and aluminum, and to understand the processes that may underlie this property. The direct assay of short-lived oxidative species was performed using a fluorescent probe, rather than measurement of more secondary indices of quantitation of damage to lipids or proteins. Issues that have been addressed include the potential of aluminum to displace iron from its intracellular binding sites, the ratio of iron to aluminum affecting such excess generation of reactive oxygen species (ROS), the
